CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

The present disclosure provides compounds and pharmaceutically acceptable salts thereof for inhibiting CYP26B1. Aspects of the present disclosure also include methods of using the compounds to treat diseases or disorders, including, but not limited to, skin disorders, cancer, neurological disorders,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HSIEH, Tom Han Hsiao, LASSUEUR, Kristiana, ARNS, Stephen Paul, PERSAUD, Rosanne, RULLO, Jacob, STURINO, Claudio, CAMERON, Donald Andrew, PENNIMPEDE, Tracie Lena, PETKOVICH, Martin, MANCINI, Joseph A, MARTINO, Giovanni, SZYCHOWSKI, Janek, TAN, Jason Samuel
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides compounds and pharmaceutically acceptable salts thereof for inhibiting CYP26B1. Aspects of the present disclosure also include methods of using the compounds to treat diseases or disorders, including, but not limited to, skin disorders, cancer, neurological disorders, heterotopic ossification (HO), fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas, and diseases or disorders of the eye, including meibomian gland dysfunction and dry eye disease. La présente invention concerne des composés et des sels pharmaceutiquement acceptables de ceux-ci pour inhiber CYP26B1. Des aspects de la présente invention comprennent également des procédés d'utilisation des composés pour traiter des maladies ou des troubles, comprenant, mais sans y être limités, des troubles cutanés, le cancer, des troubles neurologiques, l'ossification hétérotopique (HO), la fibrodysplasie ossifiante progressive (FOP), de multiples ostéochondromes, et des maladies ou des troubles de l'oeil, y compris un dysfonctionnement de la glande de Meibomius et le syndrome de l'oeil sec.